IP Library Granted Patent US 6,814,962
Granted Patent Utility
US 6,814,962 · App. 09/713,268

Recombinant viruses and their use for treatment of atherosclerosis and other forms of coronary artery disease and method, reagent, and kit for evaluating susceptibility to same

Inventors: Patrick Benoit, Patrice Denefle, Michel Perricaudet, M. E. Suzanne Lewis, Michael Hayden
Patented Case View Patent ↗
Granted: Nov 9, 2004 Filed: Nov 16, 2000
Inventors
Patrick Benoit
Patrice Denefle
Michel Perricaudet
M. E. Suzanne Lewis
Michael Hayden
Assignees (at issue)
AVENTIS PHARMA S.A.
THE UNIVERSITY OF BRITISH COLUMBIA

This patent predates the USPTO's electronic file wrapper — prosecution documents from this era exist only in the Patent Office's paper records. A certified copy of the file history can be ordered from the USPTO's paper archives.

Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,814,962
App. No.
09/713,268
Filed
2000-11-16
Granted
2004-11-09
Kind
B1